Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
17%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution1 total trials
Phase 4Post-market surveillance
1(100.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

40.0%

2 of 5 finished

Non-Completion Rate

60.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(2)
Terminated(3)
Other(1)

Detailed Status

Withdrawn3
Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (100.0%)

Trials by Status

unknown117%
withdrawn350%
completed233%

Recent Activity

0 active trials
Showing 5 of 6
completed

Measuring Hydrogen Peroxide in Exhaled Breath Condensate in COPD

NCT06788457
completed

Breath Condensate Study in Patients With Cystic Fibrosis.

NCT02056132
withdrawnphase_4

Effect of Symbicort on HAT and HDAC in Sputum Macrophages of COPD

NCT00291408
withdrawn

Biomarkers of iNOS Activity in COPD, Asthma, Healthy Control

NCT00159302
withdrawn

Markers for Chronic Obstructive Pulmonary Disease (COPD)

NCT00180622
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT06788457

Measuring Hydrogen Peroxide in Exhaled Breath Condensate in COPD

Completed
NCT02056132

Breath Condensate Study in Patients With Cystic Fibrosis.

Completed
NCT00291408Phase 4

Effect of Symbicort on HAT and HDAC in Sputum Macrophages of COPD

Withdrawn
NCT00159302

Biomarkers of iNOS Activity in COPD, Asthma, Healthy Control

Withdrawn
NCT00180622

Markers for Chronic Obstructive Pulmonary Disease (COPD)

Withdrawn
NCT02318316

"Exhaled Breath Condensate" in Allogeneic Stem Cell Recipients and the Value in Follow-up

Unknown

All 6 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
6